Search - Archive ouverte HAL Access content directly

Filter your results

78 Results
authIdHal_s : herve-watier

An Enzyme-Linked Immunosorbent Assay to Study Bevacizumab Pharmacokinetics

David Ternant , Nicolas Ceze , Thierry Lecomte , Danielle Degenne , Anne-Claire Duveau et al.
Ther. Drug Monit., 2010, 32 (5), pp.647-652
Journal articles hal-00616329v1

Therapeutic antibodies in ophthalmology Old is new again

Charlotte Magdelaine-Beuzelin , Coralie Pinault , Gilles Paintaud , Herve Watier
mAbs, 2010, 2 (2), pp.176-180. ⟨10.4161/mabs.2.2.11205⟩
Journal articles hal-00616362v1

Tumour angiogenesis inhibition by therapeutic monoclonal antibodies

Nicolas Ceze , Thierry Lecomte , Herve Watier
médecine/sciences, 2009, 25 (12), pp.1099-1104
Journal articles hal-00616397v1

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab

D. Ternant , N. Ceze , F. Piller , D. Degenne , E. Dorval et al.
Fundamental & Clinical Pharmacology, 2009, 23, pp.23-23
Journal articles hal-00616413v1

Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatment

C. Magdelaine-Beuzelin , Q. Kaas , V. Wehbi , M. Ohresser , R. Jefferis et al.
Critical Reviews in Oncology/Hematology, 2007, 64 (3), pp.210-225. ⟨10.1016/j.critrevonc.2007.04.011⟩
Journal articles istex hal-00193362v1

Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule

Philippe Gatault , Guillaume Brachet , David Ternant , Danielle Degenne , Guillaume Récipon et al.
mAbs, 2015, 7 (6), pp.1205-1211. ⟨10.1080/19420862.2015.1086049⟩
Journal articles hal-02425475v1

G1m allotypes and development of antibodies-to-infliximab.

Charlotte Magdelaine-Beuzelin , S. Vermeire , M. Goodall , Filip Baert , Marc Ohresser et al.
Immunogenicity for Biologics 2008, IBC Congress, Bâle (Suisse), 5-6 février., Feb 2008, BALE, Switzerland
Conference papers hal-00320462v1

Le point sur le développement des anticorps monoclonaux anti-rhésus D.

Hervé Watier , B. Perron
3ème Journée d'Immuno-Hématologie et Grossesse, Vouvray, 12 juin 2008., Jun 2008, VOUVRAY, France
Conference papers hal-00320465v1

Fcγ receptor IIIB gene polymorphism is a predictive factor of infectious events under adalimumab in rheumatoid arthritis patients treated in the ReACT study.

Corinne Miceli-Richard , Marc Ohresser , Philippe Goupille , Céline Verstuyft , L. Contreras et al.
Annual European Congress of Rheumatology, Paris, 11-14 June 2008., Jun 2008, PARIS, France. pp.325 (SAT0131)
Conference papers hal-00320148v1

Les anticorps monoclonaux : une avancée thérapeutique récente et majeure

Gilles Paintaud , F. Lejarre , David Ternant , Philippe Goupille , Hervé Watier et al.
Thérapie, 2009, 64, pp.1-7
Journal articles hal-00422697v1

Implications of receptors for the Fc portion of IgG (Fc gamma Rs) in mechanism of action of therapeutic antibodies

Julien Lejeune , Gilles Thibault , Guillaume Cartron , Marc Ohresser , Herve Watier et al.
Bulletin du Cancer, 2010, 97 (5), pp.511-522. ⟨10.1684/bdc.2010.1077⟩
Journal articles hal-00616358v1

Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a Randomized trial

Gert van Assche , Charlotte Magdelaine-Beuzelin , Geert d'Haens , Filip Baert , Maja Noman et al.
Gastroenterology, 2008, 134 (7), pp.1861-1868
Journal articles hal-00616945v1

Stem cell mobilization in idiopathic steroid sensitive nephrotic syndrome.

H. Lapillonne , A. Leclerc , T. Ulinski , L. Balu , Aline Garnier et al.
Pediatric Nephrology, 2008, 23, pp.1251-1256
Journal articles hal-00318030v1

Therapeutic antibodies and infectious diseases

Guillaume Desoubeaux , Arnaud Daguet , Herve Watier
Journal articles hal-02443986v1

Les anticorps thérapeutiques (conférence de vulgarisation grand public).

Hervé Watier
Cycle de conférences au CHRU de Tours à l'occasion du jubilé des 50 ans des CHU, 12 janvier 2008., Jan 2008, TOURS, France
Conference papers hal-00320510v1

Development of anti-infliximab antibodies increases infliximab clearance in chronic inflammatory bowel disease.

David Ternant , Alexandre Aubourg , Charlotte Magdelaine-Beuzelin , Danielle Degenne , Hervé Watier et al.
Congrès P2T (12ème congrès annuel de la Société Française de Pharmacologie et de Thérapeutique), Clermont-Ferrand, avril 2008., Apr 2008, Clermont-Ferrand, France. pp.22 (S1) : 23 (N°107)
Conference papers hal-00320028v1

FcgRIIIa expression is not increased on natural killer cells expressing the FcgRIIIa-158V allotype.

Nicolas Congy-Jolivet , A. Bolzec , David Ternant , Marc Ohresser , Hervé Watier et al.
3èmes Journées du Cancéropôle Grand Ouest, Nantes, 10-11 mars., Mar 2008, NANTES, France
Conference papers hal-00320385v1

Interindividual variability in the concentration-effect relationship of antilymphocyte globulins - a possible influence of FcgRIIIa genetic polymorphism.

David Ternant , M. Buchler , M. Beneton , G. Alvan , Marc Ohresser et al.
British Journal of Clinical Pharmacology, 2008, 65, pp.60-68
Journal articles hal-00318128v1

Porcine CD58: cDNA cloning and molecular dissection of the porcine CD58–human CD2 interface

Angélique Brossay , Herve Watier , Angélique Brossay , Florent Hubé , Thierry Moreau et al.
Biochemical and Biophysical Research Communications, 2003, 309 (4), pp.992-998. ⟨10.1016/j.bbrc.2003.08.099⟩
Journal articles hal-02127394v1

Infliximab pharmacokinetics in inflammatory Bowel disease patients

David Ternant , Alexandre Aubourg , Charlotte Magdelaine-Beuzelin , Danielle Degenne , Herve Watier et al.
Ther. Drug Monit., 2008, 30 (4), pp.523-529
Journal articles hal-00616549v1

FcgRIIIa Expression Is Not Increased on Natural Killer Cells Expressing the FcgRIIIa-158V Allotype.

Nicolas Congy-Jolivet , Armelle Bolzec , David Ternant , Marc Ohresser , Hervé Watier et al.
Cancer Research, 2008, 68, pp.976-980
Journal articles hal-00317889v1

Mise au point d'une méthode de dosage sérique du cétuximab appliquée au suivi thérapeutique des patients traités.

Nicolas Cézé , David Ternant , F. Piller , Danielle Degenne , Hervé Watier et al.
Journées Francophones de Pathologie Digestive, Paris, mars 2008., Mar 2008, PARIS, France. pp.51
Conference papers hal-00320376v1

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of Cetuximab

David Ternant , Nicolas Cézé , F. Piller , Danielle Degenne , E. Dorval et al.
Fundam Clin Pharmacol, Apr 2009, MARSEILLE, France
Conference papers hal-00375861v1

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop

Roch Houot , P. Gaulard , R. Schreiber , I. Mellman , O. Lambotte et al.
OncoImmunology, 2016, 5 (7), pp.e1186323. ⟨10.1080/2162402X.2016.1186323⟩
Journal articles hal-01372753v1

Tumor burden influences exposure and response to rituximab : pharmacokinetic - pharmacodynamic modelling using a syngeneic bioluminescent murine model expressing human CD20

David Dayde , David Ternant , Marc Ohresser , S. Lerondel , S. Pesnel et al.
Blood, 2009, 113, pp.3765-3772
Journal articles hal-00422647v1

Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor

V. Gouilleux-Gruart , H. Chapel , S. Chevret , M. Lucas , M. Malphettes et al.
Clinical and Experimental Immunology, 2013, 171 (2), pp.186-194. ⟨10.1111/cei.12002⟩
Journal articles hal-02425429v1
Image document

Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti–TNF-α Antibodies after a Single Injection in Mice

Christophe Arnoult , Guillaume Brachet , Diana Cadena Castaneda , Nicolas Azzopardi , Christophe Passot et al.
Journal of Immunology, 2017, 199 (2), pp.418-424. ⟨10.4049/jimmunol.1601246⟩
Journal articles hal-02019721v1

Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients

Nicolas Azzopardi , Therry Lecomte , David Ternant , Michele Boisdron-Celle , Friedrich Piller et al.
Fundamental & Clinical Pharmacology, 2011, 25, pp.34-34
Journal articles hal-00616314v1

Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritis

Hubert Marotte , Gilles Paintaud , Herve Watier , Pierre Miossec
Annals of the Rheumatic Diseases, 2008, 67 (6), pp.893-894
Journal articles hal-00616939v1

Feg receptor IIIB gene polymorphism is a predictive factor of infectious events under adalimumab in rheumatoid arthritis patients treated in the react study

Corinne Miceli-Richard , Marc Ohresser , Philippe Goupille , Celine Verstuyft , Laura Contreras et al.
Arthritis and Rheumatism, 2008, 58 (9), pp.S900-S901
Journal articles hal-00618961v1